Yvonne Lau

4PUBLICATIONS
50CO-AUTHORS
Predictive and prognostic markersMolecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Nov 19, 2025
Concentration-QTc Analysis of Valemetostat in Patients With Hematologic Malignancies.

Masaya Tachibana, Bill Poland, Yasuyuki Kakurai

|Oct 28, 2025
Effect of Valemetostat on the Pharmacokinetics of Midazolam and Digoxin: A Phase 1 Drug-Drug Interaction Study in Patients With Non-Hodgkin Lymphoma.

Masaya Tachibana, Steven Horwitz, Eric Jacobsen

|Jun 28, 2024
A Phase I/II Study of Valemetostat (DS-3201b), an EZH1/2 Inhibitor, in Combination with Irinotecan in Patients with Recurrent Small-Cell Lung Cancer.

Noura J Choudhury, W Victoria Lai, Alex Makhnin

|Jun 26, 2023
A Phase I, Multicenter, Open-Label, First-in-Human Study of DS-6157a in Patients with Advanced Gastrointestinal Stromal Tumor.

Suzanne George, Michael C Heinrich, Neeta Somaiah

Pageof 1

Frequent Collaborators

2 joint publications

Yasuyuki Kakurai

2 joint publications

Masaya Tachibana

1 joint publications

Suzanne George

1 joint publications

Michael C Heinrich